Halberd/Athena GTX Research Promises a Much Brighter Future

Halberd/Athena GTX Research Promises a Much Brighter Future pharmiweb.com Halberd Corporation 22nd May 2024 Effective medications for substance abuse and co-morbidities- specifically, effective medications for the various core substances linked to abuse with and without the co-morbidities of TBI and PTSD. LDN+: This novel combination of low dose Naltrexone and Cyclobenzaprine, patented by Halberd, has […]

The Utilization of Low Dose Naltrexone for Chronic Pain (Abstract)

The Utilization of Low Dose Naltrexone for Chronic Pain CNS Drugs 28 July 2023 https://pubmed.ncbi.nlm.nih.gov/37505425/ Naltrexone is a mu-opioid receptor antagonist with a long half-life compared with naloxone. Both of these drugs, along with others, were developed with the intention of reversing the effects of opioid abuse or toxicity. Evidence has also shown that naltrexone […]

Dawn Ipsen, PharmD – LDN Radio Show May 2023 (LDN; low dose naltrexone)

D Today we’re joined by pharmacist Dr Dawn Ipsen who’s the owner of two pharmacies in Washington State, Kuslers Pharmacy and Clark Pharmacy. Could you tell us what it was that inspired you to become a pharmacist?  I knew early on as a high schooler that I wanted to have a doctorate degree in something […]